Book a meeting
DO-BO

How does early Market Access bridge the gap between innovation and commercial success, Catherine Bacon?

Discover the newest episode of MAP, the Market Access Podcast, your go-to podcast for all things Market Access. In todays episode our host Dr. Stefan Walzer dives deep into early market access in commercialization planning, bridging the gap between innovation and market success. Joined by Catherine Bacon, founder of Fingerpost Consulting, the conversation unpacks the critical steps early-stage healthcare companies must take to ensure patient access, maximize funding, and achieve commercial success.

Explore the importance of early market access in commercialization planning. Learn how to align clinical trials, evidence generation, and payer requirements to ensure patient access and commercial success. Whether you’re aiming for a successful exit or launching your own product, this episode is packed with actionable advice to secure your path to market success by 2030 and beyond.

Tune in to the full episode and explore how Market Access 4.0 is transforming healthcare commercialization!

Related

No Decisions for Us, Without Us: Why Patient Advocacy Matters in Market Access, Erica Bersin?

By

Stefan Walzer

In this episode of the Market Access Podcast, Erica Bersin – founder of ERO Health Communications – joins Dr. Stefan Walter to discuss the changing role of patient involvement in healthcare. Drawing on her experience in both Europe and the U.S., Erica explains how single-payer systems make patient engagement easier, while the U.S. faces more […]

Can VR and AR Finally Break Through the Barriers in Medical Innovation, Günther Illert?

By

Stefan Walzer

In this episode of the Market Access Podcast, Dr. Stefan Walzer sits down with strategy consultant and XR advocate Günther Illert to explore how virtual, augmented, and extended reality are reshaping healthcare—from patient training and pain therapy to surgical planning and medtech education. Learn how cross-sector collaboration and early adoption—especially outside traditional reimbursement systems—can unlock […]

Why Should Pharma and MedTech Innovators Look at New Zealand, Julius Ohrnberger?

By

Stefan Walzer

Tune in to this new episode of MAP to explore New Zealand’s unique healthcare and reimbursement landscape with Dr. Stefan Walzer and health economist Dr. Julius Ohnberger. Learn how PHARMAC combines HTA and payer roles, why equity and Māori health outcomes are central to market access and what global pharma can gain from launching in […]